RE: RNS's1 May 2025 12:09
Disappointing results, too high a valuation, no further contracts. no barrier to other companies, impact of tariffs, usa recession possibilities.
About to break 30 pence and on the way to approx 20p....which is a fairer valuation for such a risky model. The bulls will grump and groan but meanwhile the share price slowly drifts down. One of those shares that is far riskier that many think and which may never make a profit. If insurance companies start to cancel agreements then this has little to offer. Administration would then beckon.